Journal
JOURNAL OF CLINICAL VIROLOGY
Volume 36, Issue 1, Pages 1-7Publisher
ELSEVIER
DOI: 10.1016/j.jcv.2006.01.004
Keywords
parvovirus B19; intrauterine infection; fetal anemia; intrauterine transfusion
Categories
Ask authors/readers for more resources
Parvovirus B19 is a small single-stranded DNA virus and a potent inhibitor of erythropoiesis, Clue to its cytotoxicity to erythroid progenitor cells. Infection with parvovirus B19 during pregnancy can cause several serious complications in the fetus, such as fetal anemia, neurological anomalies, hydrops fetalis, and fetal death. Early diagnosis and treatment of intrauterine parvovirus B19 infection is essential in preventing these fetal complications. Testing maternal serum for IgM antibodies against parvovirus B19 and DNA detection by PCR can confirm maternal infection. If maternal infection has occurred, ultrasound investigation of the fetus and measurement of the peak systolic flow velocity of the middle cerebral artery are sensitive non-invasive procedures to diagnose fetal anemia and hydrops. Intrauterine transfusion is Currently the only effective treatment to alleviate fetal anemia, but if the fetus is (near) term, induction of delivery should be considered. Most maternal infections with parvovirus B19 occur through contact with infected children at home. Individual counseling Of Susceptible pregnant women will reduce unnecessary fetal deaths. (C) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available